Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$8.1 million.

  • Lifecore Biomedical, Inc. \De\'s Interest & Investment Income rose 308.3% to -$8.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$21.2 million, marking a year-over-year decrease of 8205.19%. This contributed to the annual value of -$21.8 million for FY2025, which is 2070.2% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Interest & Investment Income is -$8.1 million, which was up 308.3% from -$4.8 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Interest & Investment Income ranged from a high of $27000.0 in Q3 2021 and a low of -$8.3 million during Q2 2024
  • Its 5-year average for Interest & Investment Income is -$1.6 million, with a median of $15000.0 in 2022.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Interest & Investment Income surged by 23750.0% in 2021 and then plummeted by 5567333.33% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Interest & Investment Income stood at $19000.0 in 2021, then dropped by 15.79% to $16000.0 in 2022, then dropped by 6.25% to $15000.0 in 2023, then changed by 0.0% to $15000.0 in 2024, then plummeted by 53960.0% to -$8.1 million in 2025.
  • Its Interest & Investment Income was -$8.1 million in Q2 2025, compared to -$4.8 million in Q1 2025 and $15000.0 in Q3 2024.